# R230C and C230C Variants of ABCA1 and Glyburide Response

> **NCT01456650** · PHASE4 · COMPLETED · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 85 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glyburide

## Key facts

- **NCT ID:** NCT01456650
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456650, "R230C and C230C Variants of ABCA1 and Glyburide Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01456650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*